ES2427170T3 - Mezcla de polifenoles para la prevención de la aparición de cáncer de próstata en una persona diagnosticada con alto grado de neoplasia intraepitelial de próstata (HGPIN) - Google Patents

Mezcla de polifenoles para la prevención de la aparición de cáncer de próstata en una persona diagnosticada con alto grado de neoplasia intraepitelial de próstata (HGPIN) Download PDF

Info

Publication number
ES2427170T3
ES2427170T3 ES05768182T ES05768182T ES2427170T3 ES 2427170 T3 ES2427170 T3 ES 2427170T3 ES 05768182 T ES05768182 T ES 05768182T ES 05768182 T ES05768182 T ES 05768182T ES 2427170 T3 ES2427170 T3 ES 2427170T3
Authority
ES
Spain
Prior art keywords
catechins
mixture
egcg
prostate
prostate cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05768182T
Other languages
English (en)
Spanish (es)
Inventor
Saverio Bettuzzi
Arnaldo Corti
Sergio Corvetta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genprofiler Srl
Original Assignee
Genprofiler Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITBZ20040037 external-priority patent/ITBZ20040037A1/it
Priority claimed from ITBZ20050004 external-priority patent/ITBZ20050004A1/it
Application filed by Genprofiler Srl filed Critical Genprofiler Srl
Application granted granted Critical
Publication of ES2427170T3 publication Critical patent/ES2427170T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
ES05768182T 2004-07-27 2005-07-21 Mezcla de polifenoles para la prevención de la aparición de cáncer de próstata en una persona diagnosticada con alto grado de neoplasia intraepitelial de próstata (HGPIN) Expired - Lifetime ES2427170T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITBZ20040037 2004-07-27
ITBZ20040037 ITBZ20040037A1 (it) 2004-07-27 2004-07-27 Miscela di catechine ovvero polifenoli estratti dal te' verde cinese o da altri vegetali con efficacia chemiopreventiva per la prevenzione dell'insorgenza del cancro prostatico.
ITBZ20050004 ITBZ20050004A1 (it) 2005-02-16 2005-02-16 Miscela di catechine ovvero polifenoli estratti dal Te' Verde cinese (o da altri vegetali) Efficacia chemiopreventiva per la prevenzione dell'insorgenza del cancro prostatico e per il trattamento efficace della sintomatologia dell'ipertrofia prostati
ITBZ20050004 2005-02-16
PCT/IB2005/002107 WO2006013420A2 (en) 2004-07-27 2005-07-21 Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph)

Publications (1)

Publication Number Publication Date
ES2427170T3 true ES2427170T3 (es) 2013-10-29

Family

ID=35447932

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05768182T Expired - Lifetime ES2427170T3 (es) 2004-07-27 2005-07-21 Mezcla de polifenoles para la prevención de la aparición de cáncer de próstata en una persona diagnosticada con alto grado de neoplasia intraepitelial de próstata (HGPIN)

Country Status (7)

Country Link
US (1) US8044095B2 (enExample)
EP (1) EP1781375B1 (enExample)
JP (2) JP2008508252A (enExample)
CA (1) CA2612149C (enExample)
ES (1) ES2427170T3 (enExample)
PL (1) PL1781375T3 (enExample)
WO (1) WO2006013420A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009053857A2 (en) * 2007-10-26 2009-04-30 Csir Management and treatment of benign prostatic hyperplasia
FR2930443B1 (fr) 2008-04-29 2010-06-25 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12
AU2009306592B2 (en) * 2008-10-20 2013-05-23 Unilever Global Ip Limited An antimicrobial composition
CA2801143C (en) 2009-09-24 2017-09-26 Unilever Plc Disinfecting agent comprising eugenol, terpineol and thymol
MX2013006435A (es) 2010-12-07 2013-07-03 Unilever Nv Composicion para cuidado oral.
US9693941B2 (en) 2011-11-03 2017-07-04 Conopco, Inc. Liquid personal wash composition
EP2782550A2 (en) * 2011-11-25 2014-10-01 Unilever N.V. An oral care composition comprising polyphenol
WO2013081046A1 (ja) * 2011-11-29 2013-06-06 国立大学法人信州大学 ブドウ梗由来抽出物
CN102754832A (zh) * 2012-07-12 2012-10-31 赵四海 用酚和醌融解肿瘤和改造癌细胞的治病方法
WO2014062677A1 (en) * 2012-10-15 2014-04-24 Kemin Industries, Inc. A blend of green and black extracts for the promotion of health benefits
KR101492713B1 (ko) * 2013-05-06 2015-02-12 대구한의대학교산학협력단 미숙 떫은 감의 분획물을 이용한 전립선 비대증 예방 또는 치료용 조성물
US11839639B2 (en) 2017-10-19 2023-12-12 Yale University Inhibition of androgen receptor by extracts of medicinal herbs and compositions thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266977A (en) * 1991-07-12 1993-11-30 Linden Harry A Lens device and method
US5585871A (en) * 1995-05-26 1996-12-17 Linden; Harry Multi-function display apparatus
US6696484B2 (en) 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
DE19842858A1 (de) 1998-09-18 2000-03-30 Vollbrecht H Ruediger Entkoffeinierung von Tee
KR100319973B1 (ko) 1998-12-05 2002-04-22 이인수 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물
AU4043900A (en) * 1999-03-30 2000-10-16 Purdue Research Foundation Compositions containing tea catechins as cancer specific proliferation inhibitors
US6410052B1 (en) * 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
US6431705B1 (en) * 1999-11-10 2002-08-13 Infoeye Eyewear heart rate monitor
WO2002067966A1 (en) * 2001-02-22 2002-09-06 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
WO2002067965A1 (en) 2001-02-22 2002-09-06 Purdue Research Foundation Compositions based on proanthocyanadin-catechin synergies for prevention and treatment of cancer

Also Published As

Publication number Publication date
CA2612149C (en) 2015-11-10
WO2006013420A2 (en) 2006-02-09
PL1781375T3 (pl) 2013-11-29
EP1781375B1 (en) 2013-06-19
JP2008508252A (ja) 2008-03-21
JP2012236834A (ja) 2012-12-06
US20080194675A1 (en) 2008-08-14
EP1781375A2 (en) 2007-05-09
WO2006013420B1 (en) 2006-06-08
CA2612149A1 (en) 2006-02-09
US8044095B2 (en) 2011-10-25
WO2006013420A3 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
Badolato et al. From the hive: Honey, a novel weapon against cancer
Rauf et al. Anticancer potential of quercetin: A comprehensive review
Mei et al. Diosmetin alleviated cerebral ischemia/reperfusion injury in vivo and in vitro by inhibiting oxidative stress via the SIRT1/Nrf2 signaling pathway
Chen et al. Tea and human health: biomedical functions of tea active components and current issues
Martin et al. Polyphenols as dietary supplements: A double-edged sword
R Ramis et al. Protective effects of melatonin and mitochondria-targeted antioxidants against oxidative stress: a review
Mirazimi et al. Application of quercetin in the treatment of gastrointestinal cancers
Rondanelli et al. A systematic review on the effects of botanicals on skeletal muscle health in order to prevent sarcopenia
ES2427170T3 (es) Mezcla de polifenoles para la prevención de la aparición de cáncer de próstata en una persona diagnosticada con alto grado de neoplasia intraepitelial de próstata (HGPIN)
Huang et al. Genistein reduced the neural apoptosis in the brain of ovariectomised rats by modulating mitochondrial oxidative stress
Huang et al. Inhibition effects of chlorogenic acid on benign prostatic hyperplasia in mice
Cerri et al. Sclareol-loaded lipid nanoparticles improved metabolic profile in obese mice
JP2004516257A (ja) 糖尿病性神経障害の治療に対する組成物及びその方法
Bawono et al. The role of catechins of Camellia sinensis leaves in modulating antioxidant enzymes: A review and case study
R Nunes et al. Can tea consumption be a safe and effective therapy against diabetes mellitus-induced neurodegeneration?
Qadir Role of green tea flavonoids and other related contents in cancer prevention
KR20190090910A (ko) 나노화된 꿀벌 화분을 유효성분으로 포함하는 양성 전립선 비대증 개선용 조성물
Rani et al. Phytochemical, pharmacological and beneficial effects of green tea
Ji et al. Plant-derived polyphenolic compounds for managing schizophrenia: mechanisms and therapeutic potential
Shukla et al. Apigenin and cancer chemoprevention
Wang et al. Quercus salicina Blume: research progress in chemistry and pharmacodynamics (1959–2021)
Ahmed et al. Discovery of green tea polyphenol-based antitumor drugs: mechanisms of action and clinical implications
Leigh Health benefits of grape seed proanthocyanidin extract (GSPE)
Tan et al. Antioxidant and Age-Related Diseases
Noviana et al. Synergistic Protective Effect of Commercial Nigella Sativa Oil and Honey Combination against Cisplatin-induced Nephrotoxicity in Rats Efek Protektif Sinergis Kombinasi Minyak Jintan Hitam (Nigella sativa) Komersial dan Madu terhadap Nefrotoksisitas pada